↓ Skip to main content

Oral non-steroidal anti-inflammatory drug therapy for lung disease in cystic fibrosis

Overview of attention for article published in this source, June 2013
Altmetric Badge

Mentioned by

policy
1 policy source
twitter
6 X users

Citations

dimensions_citation
35 Dimensions

Readers on

mendeley
47 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Oral non-steroidal anti-inflammatory drug therapy for lung disease in cystic fibrosis
Published by
John Wiley & Sons, Ltd, June 2013
DOI 10.1002/14651858.cd001505.pub3
Pubmed ID
Authors

Lands, Larry C, Stanojevic, Sanja

Abstract

Progressive lung damage causes most deaths in cystic fibrosis (CF). Non-steroidal anti-inflammatory drugs (NSAIDs) may prevent progressive pulmonary deterioration and morbidity in CF.

X Demographics

X Demographics

The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 47 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Netherlands 1 2%
Unknown 46 98%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 7 15%
Student > Bachelor 7 15%
Researcher 5 11%
Student > Postgraduate 3 6%
Student > Master 3 6%
Other 8 17%
Unknown 14 30%
Readers by discipline Count As %
Medicine and Dentistry 16 34%
Nursing and Health Professions 5 11%
Biochemistry, Genetics and Molecular Biology 4 9%
Agricultural and Biological Sciences 3 6%
Mathematics 2 4%
Other 4 9%
Unknown 13 28%